Oracle has introduced Life Sciences Data Intelligence 1, a cloud-native platform that integrates real-world health data, domain-trained AI, and advanced analytics to help pharmaceutical researchers generate actionable insights faster. The platform uses natural language processing to refine patient cohorts, automate workflows, and provide transparent, traceable evidence from over 122 million de-identified patient records. This unified solution enhances research efficiency across clinical trials, health economics, and market access, supporting better decision-making throughout the drug development lifecycle. Oracle's technology aims to bridge data fragmentation and accelerate discovery to commercialization in life sciences.
Oracle Corporation shares trade at USD 148.36 on Pluang as of Sep 23, 2026 19:14 WIB, showing a slight 0.51% decline in one day. Despite the recent dip, Oracle maintains a substantial market capitalization of $451.14 billion and a dividend yield of 1.34%. This trading activity occurs as Oracle advances its Life Sciences Data Intelligence platform, aiming to accelerate clinical research and drug commercialization.
Oracle Health announced new AI capabilities in its revenue cycle management portfolio to help U.S. healthcare organizations reduce reimbursement issues early in the patient and payment process. These AI tools will automate and connect workflows acros...
The Buck Institute is partnering with Oracle to utilize Oracle Life Sciences Data Intelligence, which includes over 122 million de-identified health records, to advance research on aging and age-related diseases. This collaboration aims to develop pr...
Co-op Live, the UK's largest live entertainment arena, has adopted Oracle Simphony Cloud POS and Oracle NetSuite to integrate its food and beverage services with financial management. This technology helps optimize inventory, simplify business proces...
Oracle is gaining recognition as a leading AI cloud infrastructure provider, driven by massive investments in data centers and a substantial increase in remaining performance obligations (RPO) to $664 billion. This has fueled a 121% year-over-year gr...
Leading US AI companies like Google, Microsoft, Meta, Oracle, and Amazon are driving economic growth with heavy capital spending. However, their rapid investment and financial moves, including Alphabet's $80 billion equity raise and unclear AI spendi...
